Granules India Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Granules India Limited with three other
companies in this sector in India:
Nectar Lifesciences Limited
sales of 18.77 billion Indian Rupees [US$272.50 million]
Dishman Carbogen Amcis Ltd
(16.95 billion Indian Rupees [US$246.08 million]
(19.69 billion Indian Rupees [US$285.83 million]
During the year ended March of 2018, sales at
Granules India Limited were 16.85 billion Indian Rupees (US$244.61 million).
increase of 19.4%
versus 2017, when the company's sales were 14.11 billion Indian Rupees.